CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Committee
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Sample Issue
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Advertisers
For Subscribers
Subscription Prices
Customer Service

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter youtube

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

 

Article << Previous     |     Next >>   Contents Vol 9(1)

Condom use around the globe: how can we fulfil the prevention potential of male condoms?

Lee Warner A C , Maria F. Gallo A and Maurizio Macaluso B

A National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30341 USA.
B Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
C Corresponding author. Email: dlw7@cdc.gov

Sexual Health 9(1) 4-9 http://dx.doi.org/10.1071/SH11072
Submitted: 13 May 2011  Accepted: 19 September 2011   Published: 17 February 2012


 
 Full Text
 PDF (211 KB)
 Export Citation
 Print
  
Abstract

Despite a global epidemic of sexually transmissible infections and the availability and endorsement of condoms as an effective intervention, the overall use of condoms remains low. This review explores various challenges and opportunities to fully realizing the prevention potential for condoms.



References

[1]  UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Available online at: www.unaids.org/documents/20101123_GlobalReport_em.pdf [verified March 2011].

[2]  Gerbase AC, Rowley JT, Heymann DH, Berkley SF, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74: S12–6.

[3]  Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S. Murray CJL and the Comparative Risk Assessment Collaborating Group*. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–60.
CrossRef |

[4]  Collier A. The humble little condom: a history. Amherst, NY: Prometheus Books; 2007.

[5]  Allen P. Condom: one small item, one giant impact. Oxford: New Internationalist Ltd.; 2007.

[6]  Halperin DT, Steiner MJ, Cassell MM, Green EC, Hearst N, Kirby D, et al The time has come for common ground on preventing sexual transmission of HIV. Lancet 2004; 364: 1913–5.
CrossRef |

[7]  UNAIDS. Condoms and HIV prevention: position statement by UNAIDS, UNFPA and WHO. Geneva: UNAIDS; 2009. Available online at: www.unaids.org/en/resources/presscentre/featurestories/2009/march/20090319preventionposition/ [verified March 2011].

[8]  United Nations Population Fund (UNFPA). Donor support for contraceptives and condoms for STI/HIV prevention. New York: UNFPA; 2008.

[9]  UNAIDS. Making condoms work for HIV prevention: cutting-edge perspectives. Geneva: UNAIDS; 2004.

[10]  Workowski KA, Berman SM, Centers for Disease Control and Prevention (CDC) Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 2010; 59: 1–110.

[11]  Carey RF, Lytle CD, Cyr WH. Implications of laboratory tests of condom integrity. Sex Transm Dis 1999; 26: 216–20.
CrossRef | CAS |

[12]  Carey RF, Herman WA, Retta SM, Rinaldi JE, Herman BA, Athey TW. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sex Transm Dis 1992; 19: 230–4.
CrossRef | CAS |

[13]  Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS 1987; 1: 49–52.
| CAS |

[14]  Rietmeijer CA, Krebs JW, Feorino PM, Judson FN. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA 1988; 259: 1851–3.
CrossRef | CAS |

[15]  Cates W. The NIH condom report: the glass is 90% full. Fam Plann Perspect 2001; 33: 231–3.
CrossRef |

[16]  Boonstra H. Public health advocates say campaign to disparage condoms threatens STD prevention efforts. Guttmacher Rep Public Policy 2003; 6: 1–3.

[17]  Gilden D. Condom effectiveness, reviewed, revised, reduxed. New York: Community HIV/AIDS Mobilization Project (CHAMP) HHS Watch; 2005. Available online at: http://www.champnetwork.org/media/HHSWatch0705.pdf [verified March 2011].

[18]  Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33: 36–51.
CrossRef |

[19]  Crosby RA, Bounse S. Condom effectiveness: where are we now? Sex Health 2012; 9: 10–17.

[20]  Crosby R, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002; 78: 228–31.
CrossRef | CAS |

[21]  Steiner MJ, Feldblum PJ, Padian N. Invited commentary: condom effectiveness – will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol 2003; 157: 298–300.
CrossRef |

[22]  Taylor D. Issues in the design, analysis and interpretation of condom functionality studies. Contraception 2009; 80: 237–44.
CrossRef |

[23]  Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav 2006; 35: 327–45.
CrossRef |

[24]  Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR. Condom use errors and problems: a global view. Sex Health 2012; 9: 81–95.

[25]  Lagakos SW, Gable AR (editors). Methodological challenges in biomedical HIV prevention trials. Washington DC: National Academies Press; 2008.

[26]  National Institute of Allergy and Infectious Diseases (NIAID). Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Bethesda, MD: NIAID; 2001.

[27]  Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; : CD003255.
| CAS |

[28]  Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82: 454–61.

[29]  Koss CA, Dunne EF, Warner L. A systematic review of epidemiologic studies assessing condom use and risk of syphilis. Sex Transm Dis 2009; 36: 401–5.
CrossRef |

[30]  Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, et al A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009; 169: 1233–40.
CrossRef |

[31]  Wald A, Langenberg AG, Krantz E, Douglas JM, Handsfield HH, DiCarlo RP, et al The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143: 707–13.

[32]  Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK, et al Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354: 2645–54.
CrossRef | CAS |

[33]  Warner L, Newman D, Peterman T, Kamb M, Douglas JM, Zenilman J, et al Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159: 242–51.
CrossRef |

[34]  Warner L, Macaluso M, Austin HD, Kleinbaum DK, Artz L, Fleenor ME, et al Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161: 765–73.
CrossRef |

[35]  Macaluso M, Blackwell R, Jamieson DJ, Kulczycki A, Chen MP, Akers R, et al Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol 2007; 166: 88–96.
CrossRef |

[36]  Crosby R, Warner L. Pending research issues in male condom use promotion. Sex Health 2008; 5: 317–9.
CrossRef |

[37]  Mauck CK, Doncel GF. Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception 2007; 75: 407–19.
CrossRef | CAS |

[38]  Duerr A, Gallo MF, Warner L, Jamieson DJ, Kulczycki A, Macaluso M. Measures of male condom failure and incorrect use. Sex Transm Dis 2011; : .

[39]  Crosby R, DiClemente RJ, Charnigo R, Snow G, Troutman A. A brief, clinic-based, safer sex intervention for heterosexual African American men newly diagnosed with an STD: a randomized controlled trial. Am J Public Health 2009; 99: S96–103.
CrossRef |

[40]  Keiser NH. Strategies of media marketing for “America Responds to AIDS” and applying lessons learned. Public Health Rep 1991; 106: 623–7.
| CAS |

[41]  Centers for Disease Control and Prevention (CDC) Evolution of HIV/AIDS prevention programs – United States, 1981–2006. MMWR Morb Mortal Wkly Rep 2006; 55: 597–603.

[42]  Pazol K, Warner L, Gavin L, Callaghan WM, Spitz AM, Anderson JE, et al Teen pregnancy – United States, 1991–2009. MMWR Morb Mortal Wkly Rep 2011; 60: 414–20.

[43]  Fortenberry JD, Schick V, Herbenick D, Sanders SA, Dodge B, Reece M. Sexual behaviors and condom use at last vaginal intercourse: a national sample of adolescents ages 14 to 17 years. J Sex Med 2010; 7: 305–14.
CrossRef |

[44]  Anderson J, Warner L, Macaluso M. Condom use among U.S. adults at last sexual intercourse, 1996–2008: an update from national survey data. Sex Transm Dis 2011; 38: 919–21.

[45]  Sanders SA, Reece M, Herbenick D, Schick V, Dodge B, Fortenberry JD. Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States. J Sex Med 2010; 7: 362–73.
CrossRef |

[46]  Godeau E, Gabhainn SN, Vignes C, Ross J, Boyce W, Todd J. Contraceptive use by 15-year-old students at their last sexual intercourse: results from 24 countries. Arch Pediatr Adolesc Med 2008; 162: 66–73.
CrossRef |

[47]  Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al Sexual behaviour in Britain: partnership, practices, and HIV risk behaviours. Lancet 2001; 358: 1835–42.
CrossRef | CAS |

[48]  Adair T. Men’s condom use in higher-risk sex: trends and determinants in five sub-Saharan countries. DHS Working Paper 2008; 34: 1–29.

[49]  Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370: 251–61.
CrossRef |

[50]  Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1977–87.
CrossRef | CAS |

[51]  Van Damme L, Govinden R, Mirembe FM, Guédou F, Solomon S, Becker ML, et al Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359: 463–72.
CrossRef | CAS |

[52]  McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376: 1329–37.
CrossRef | CAS |

[53]  Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168–74.
CrossRef | CAS |

[54]  Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, et al Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; : .
CrossRef |

[55]  Warner L, Newman DR, Kamb ML, Fishbein M, Douglas JM, Zenilman J, et al Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia. Am J Epidemiol 2008; 167: 341–9.
CrossRef |

[56]  Crosby RA, Yarber WL, Graham CA, Sanders SA. Does it fit okay? Problems with condom use as a function of self-reported poor fit. Sex Transm Infect 2010; 86: 36–8.
CrossRef | CAS |

[57]  Khan SI, Hudson-Rodd N, Saggers S, Bhuiyan MI, Bhuiya A. Safer sex or pleasurable sex? Rethinking condom use in the AIDS era. Sex Health 2004; 1: 217–25.
CrossRef |

[58]  Graham CA, Crosby R, Yarber WL, Sanders SA, McBride K, Milhausen RR, et al Erection loss in association with condom use among young men attending a public STI clinic: potential correlates and implications for risk behaviour. Sex Health 2006; 3: 255–60.
CrossRef |

[59]  Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices. Implications for evaluating method and user effectiveness. Sex Transm Dis 1998; 25: 273–7.
CrossRef | CAS |

[60]  Paz-Bailey G, Koumans EH, Sternberg M, Pierce A, Papp J, Unger ER, et al The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med 2005; 159: 536–42.
CrossRef |

[61]  Calzavara L, Burchell AN, Remis RS, Major C, Corey P, Myers T, et al Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol 2003; 157: 210–7.
CrossRef |

[62]  Hatherall B, Ingham R, Stone N, McEachran J. How, not just if, condoms are used: the timing of condom application and removal during vaginal sex among young people in England. Sex Transm Infect 2007; 83: 68–70.
CrossRef | CAS |

[63]  Hensel DJ, Stupiansky NW, Herbenick D, Dodge B, Reece M. When condom use is not condom use: an event-level analysis of condom use behaviors during vaginal intercourse. J Sex Med 2011; 8: 28–34.
CrossRef |

[64]  Albert AE, Warner DL, Hatcher RA, Trussell J, Bennett C. Condom use among female commercial sex workers in Nevada’s legal brothels. Am J Public Health 1995; 85: 1514–20.
CrossRef | CAS |

[65]  Macaluso M, Kelaghan J, Artz L, Austin H, Fleenor M, Hook EW, et al Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis 1999; 26: 450–8.
CrossRef | CAS |

[66]  Spruyt A, Steiner MJ, Joanis C, Glover LH, Piedrahita C, Alvarado G, et al Identifying condom users at risk for breakage and slippage: findings from three international sites. Am J Public Health 1998; 88: 239–44.
CrossRef | CAS |

[67]  Steiner M, Piedrahita C, Glover L, Joanis C. Can condom users likely to experience condom failure be identified? Fam Plann Perspect 1993; 25: 220–3, 226.
CrossRef | CAS |

[68]  Cecil M, Nelson A, Trussell J, Hatcher R. If the condom doesn’t fit, you must resize it. Contraception 2010; 82: 489–90.
CrossRef |

[69]  Trussell J, Warner DL, Hatcher RA. Condom slippage and breakage rates. Fam Plann Perspect 1992; 24: 20–3.
CrossRef | CAS |

[70]  Cook L, Nanda K, Taylor D. Randomized crossover trial comparing the eZ. on plastic condom and a latex condom. Contraception 2001; 63: 25–31.
CrossRef | CAS |

[71]  Gallo MF, Grimes DA, Lopez LM, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 2006; 1: CD003550.

[72]  Gallo M, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health 2011; 9: 18–26.

[73]  Anonymous. Condoms: a global strategic business report. San Jose: Global Industry Analysts Inc.; 2008.

[74]  Macaluso M, Demand MJ, Artz LM, Hook EW. Partner type and condom use. AIDS 2000; 14: 537–46.
CrossRef | CAS |

[75]  United Nations Population Fund (UNPFA). State of world population 2005. The promise of equality, gender equity, reproductive health and the millennium development goals. New York: UNPF; 2005.

[76]  Marston C, King E. Factors that shape young people’s sexual behaviour: a systematic review. Lancet 2006; 368: 1581–6.
CrossRef |

[77]  Corbett AM, Dickson-Gómez J, Hilario H, Weeks MR. A little thing called love: condom use in high-risk primary heterosexual relationships. Perspect Sex Reprod Health 2009; 41: 218–24.
CrossRef |

[78]  Thomsen S, Stalker M, Toroitich-Ruto C. Fifty ways to leave your rubber: how men in Mombasa rationalise unsafe sex. Sex Transm Infect 2004; 80: 430–4.
CrossRef | CAS |

[79]  Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women’s Well-Being and Sexuality Study. Sex Health 2008; 5: 321–30.
CrossRef |

[80]  Philpott A, Knerr W, Maher D. Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy. Lancet 2006; 368: 2028–31.
CrossRef |

[81]  Randolph ME, Pinkerton SD, Bogart LM, Cecil H, Abramson PR. Sexual pleasure and condom use. Arch Sex Behav 2007; 36: 844–8.
CrossRef |

[82]  Charania MR, Crepaz N, Guenther-Gray G, Henny K, Liau A, Willis LA, et al Efficacy of structural-level condom distribution interventions: a meta-analysis of U.S. and international studies, 1998. AIDS Behav 2011; 15: 1283–97.

[83]  UNAIDS. Condom social marketing: selected case studies. Geneva: UNAIDS; 2000.

[84]  Okie S. Fighting HIV – lessons from Brazil. N Engl J Med 2006; 354: 1977–81.
CrossRef | CAS |

[85]  Singh S, Darroch JE, Bankole A. A, B and C in Uganda: the roles of abstinence, monogamy and condom use in HIV decline. Reprod Health Matters 2004; 12: 129–35.
CrossRef |

[86]  Sun X, Lu F, Wu Z, Poundstone K, Zeng G, Xu P, et al Evolution of information-driven HIV/AIDS policies in China. Int J Epidemiol 2010; 39: ii4–13.
CrossRef |


   
 
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2014